Reversible posterior leukoencephalopathy syndrome in a child treated with bevacizumab

Keyphrases

• Bevacizumab 100%
• Posterior Reversible Encephalopathy Syndrome 100%
• Vascular Endothelial Growth Factor 40%
• Monoclonal Antibody 20%
• Hypertension 20%
• Pediatric 20%
• Antibody Targeting 20%
• Seizure 20%
• Gemcitabine 20%
• Blood Pressure Control 20%
• Neurological Sequelae 20%
• Blocking Agent 20%
• Risk Perception 20%
• Aggressive Management 20%
• Oxaliplatin 20%
• 6-year-old children 20%
• MRI Changes 20%
• Hypertensive Crisis 20%
• Blastoma 20%

Medicine and Dentistry

• Bevacizumab 100%
• Posterior Reversible Encephalopathy Syndrome 100%
• Vasculotropin 40%
• Sequela 20%
• Blood Pressure 20%
• Monoclonal Antibody 20%
• Pediatrics 20%
• Magnetic Resonance Imaging 20%
• Epileptic Seizure 20%
• Side Effect 20%
• Gemcitabine 20%
• Blocking Agent 20%
• Pressure Control 20%
• Oxaliplatin 20%
• Hypertensive Crisis 20%
• Blastoma 20%